Macrolide resistance in Mycobacterium avium can be detected with an adaption of a commercially available RNA/RNA duplex mismatch assay (Ambion, Austin, Tex.). The sensitivity and specificity values for the assay were 100% when evaluated against 41 macrolide-resistant and -susceptible strains of M. avium. Resistant subpopulations of ϳ20% could be readily detected. The assay is simple to perform and interpret, inexpensive, and rapid (<24-h turnaround).
The macrolides azithromycin (AZM) and clarithromycin (CLM) are two of the most active agents in the treatment of Mycobacterium avium complex (MAC) disease; however, macrolide resistance develops with AZM or CLM monotherapy, leading to clinical and microbiological relapse (3, 6, 7, 9, 10) . Resistance is also a concern with the prophylactic use of macrolides. In recent trials, 9% of patients on AZM prophylaxis (5) and 5% of patients on CLM prophylaxis (2) developed breakthrough MAC bacteremia. A total of 11 and 58% of the AZM and CLM breakthrough isolates, respectively, were macrolide resistant (1, 5). Clearly, the ability to rapidly and accurately detect macrolide resistance would be useful in the management of MAC disease.
Clinically significant macrolide resistance in MAC is associated almost exclusively with a point mutation in the peptidyltransferase region of the 23S rRNA gene (9, 10) . There has been one report of macrolide-resistance in MAC following therapeutic failure in which a mutation in the 23S rRNA gene was not found (4) ; however, such isolates appear to be rare and of unknown clinical significance.
We evaluated an adaption of a commercial, rapid molecular assay for detecting the presence of resistance-associated mutations within the 23S rRNA gene of M. avium. The assay involves the use of the Mismatch Detect nonisotopic RNase cleavage assay (NIRCA; Ambion Inc., Austin, Tex.), which is based on the ability of RNase A to selectively cleave unpaired bases in RNA/RNA duplexes. Therefore, if an RNA strand containing a point mutation is hybridized with a wild-type complementary RNA strand and treated with RNase A, the RNA/RNA duplex will be cleaved at the site of the mismatched bases. Directional, single-stranded RNA (ssRNA) can be transcribed from PCR products generated with primers containing different opposing RNA polymerase promoters, with the test ssRNA being transcribed with one RNA polymerase and the reference, wild-type ssRNA being transcribed with the reciprocal polymerase. Following hybridization and RNase treatment, the RNA/RNA duplexes are analyzed by nondenaturing, agarose gel electrophoresis.
For the application of the Mismatch Detect assay to detect mutations in the 23S rRNA gene of M. avium, MAC 101 was used as a reference strain. This strain is susceptible to CLM and AZM and has a wild-type 23S rRNA gene (10) . The mismatch assay was tested against 22 macrolide-susceptible strains and 19 macrolide-resistant strains of M. avium (Table  1 ). All the susceptible strains were originally isolated from patients with disseminated MAC disease prior to the start of therapy. Fourteen of the resistant strains were isolated from patients during treatment with a macrolide, and five macrolideresistant strains (MAC 101R, MAC 184, MAC 199, MAC 205, and MAC 210) were isolated from beige mice initially infected with MAC 101 and treated with CLM (generously supplied by L. E. Bermudez, Kuzell Institute, San Francisco, Calif.). Susceptibility of the M. avium strains was determined by a radiometric broth macrodilution assay and the T100 method of data analysis (8) . Resistance to CLM and AZM was defined as MICs of Ն32 and Ն256 g/ml, respectively. M. avium strains were prepared for PCR by being heated in sterile, doubledistilled H 2 O for 20 min at 95 to 100ЊC. Aliquots of the processed materials were stored at Ϫ20ЊC.
Initially, the test and reference strains were PCR amplified with primers MD23.6T7 and MD23.7SP6 (Table 2) , and then RNA was transcribed from the PCR products of the test strains with SP6 RNA polymerase or from the reference strain with T7 RNA polymerase. Alternatively, separate PCR primer pairs were used for the test strains (23.6 and MD23.7SP6) and for the reference strain (MD23.6SP6 and 23.7). With the use of separate primer pairs, ssRNA from each test strain could be transcribed with SP6 RNA polymerase in the same reaction as the reference strain, which greatly simplifies the post-PCR steps of the assay. The direction of transcription of the test and reference ssRNA in this system avoids the possibility of G-U base pairing in the RNA/RNA duplex at the mutation site; G-U mismatches are relatively resistant to RNase A cleavage.
The 50-l PCR amplification reaction mixture was composed of 10 mM Tris-Cl (pH 8.3), 5 mM KCl, 2.5 mM MgCl 2 , 0.2 mM deoxynucleoside triphosphate, 10 pmol of each primer, 1.2 U of Taq polymerase, and 0.3 g of TaqStart antibody (ClonTech, Palo Alto, Calif.); 5 l of processed DNA was added per reaction mixture. The reaction mixtures were placed in a Gene-Amp PCR System 9600 thermocycler (Perkin Elmer, Alameda, Calif.) for 35 to 40 cycles with the following temperatures and times: 94ЊC for 30 s, 55ЊC for 30 s, and 72ЊC for 40 s. Amplification product yields were estimated by mixing 2 l of PCR product with 2 l of ethidium bromide (2 g/ml) and photographing the spots under UV light with type 52 Polaroid film. The product yield was considered adequate when the intensity of the spots was greater than the intensity of the spots from the amplification control without DNA. The amplification products were sequenced on an ABI model 373A sequencer (Applied Biosystems, San Francisco, Calif.) as previously described (10) .
ssRNA was transcribed from the test and reference amplification products according to the manufacturer's guidelines (Ambion, Inc.). All reagents were included in the Mismatch Detect kit with the exception of the amplification products. Briefly, for each test strain, a 10-l reaction mixture was prepared with 2 l (20 to 100 ng of DNA) of the reference amplification product, 2 l (Ͼ5 ng of DNA) of the test strain amplification product, 3 l of RNase-free H 2 
and incubated at 37ЊC for 30 min. The RNase reactions were stopped by the addition of 4 l of RNase no. 1 gel-loading buffer, and the products were immediately loaded onto a 4-to 5-cm long 3% Nusieve 3:1 agarose (Intermountain Scientific, Bountiful, Utah) gel containing 0.25 g of ethidium bromide (Sigma) per ml; the running buffer was 0.5ϫ Tris-borate-EDTA buffer (Intermountain Scientific). The electrophoresis conditions were 7.5 to 9 V/cm for 1 h at room temperature, and the gels were photographed with type 52 Polaroid film.
Typical mismatch assay results are shown in Fig. 1 and a summary of the results for the 41 strains analyzed is shown in Table 1 . All the resistant strains generated cleavage products indicative of a mutation in the target sequence, even in strains in which the mismatch was potentially difficult to detect, the C-A nucleotide pair (e.g., MAC 101R, MAC 513, and TDH2). All of the macrolide-susceptible strains generated RNA/RNA hybrids that were resistant to RNase cleavage, indicating that the macrolide-susceptible strains had a wild-type sequence. Thus, the sensitivity and specificity of the mismatch assay are both 100%.
One strain, 49-265, was scored as being resistant by the mismatch assay; however, by DNA sequencing, the isolate was the wild type, i.e., no mutation was detected. The isolate was subcultured in a quantitative manner on Middlebrook 7H11 with and without 64 g of CLM per ml and only 20% of the CFUs were CLM resistant. Sequence analysis of the CLMresistant subpopulation of strain 49-265 showed an A to C base substitution (A3C) at position 2275 in the 23S rRNA gene. We concluded that the initial discrepancy between the mismatch assay and sequencing results was due to the insensitivity of Taq DNA polymerase-based sequencing. Other sequencing protocols, such as those with Sequenase, may improve the sequence resolution; however, the analysis of mixed popula- 
The MIC was determined by radiometric broth macrodilution and the T100 method of data analysis (8) . ND, not determined.
b The residue at position 2274 or 2275 (JWT2, 184, 199, 205, and 210) of the complete 23S rRNA gene of M. avium (genBank accession no. X74494) was determined by direct sequencing: N, more than one possible base substitution (C, G, or T) detected at position 2274; -, no mutation detected (wild type).
c S, susceptibility pattern; R, resistance pattern. d Sequence and susceptibility results are from the data in reference 10. tions of macrolide-susceptible and -resistant strains is likely to result in a base ambiguity at the mutation site. Thus, an interpretation of resistance would be based on an ambiguous result. The ability of the mismatch assay to detect resistant subpopulations of MAC was investigated by applying the assay to known mixtures of MAC 101 and MAC 101R (confirmed by quantitative culture with and without CLM). The mutation present in strain 101R (A-22743G) is the most difficult to detect by the mismatch assay and, therefore, allowed for a rigorous evaluation of the mismatch assay. The assay was able to unambiguously and reproducibly detect resistance within a mixture of 20% MAC 101R and 80% MAC 101 but not in a mixture of 2% MAC 101R and 98% MAC 101 (data not shown).
The sensitivity of the PCR stage of the mismatch assay was assessed by using a dilution series of MAC 109, ranging from 10 3 to 10 8 CFUs/ml. A sufficient amount of the amplification product for analysis by the mismatch assay was generated provided that an amount of DNA equivalent to 200 CFUs was added to each PCR mixture; this sensitivity could be increased at least 10-fold by reamplifying the PCR products with the same primers (data not shown).
Other molecular assays have been developed to detect drug resistance-associated, single-base mutations in mycobacteria, such as single-strand conformation polymorphism-PCR (11, 12) and heteroduplex analysis (13) . These assays are technically simpler and cheaper than sequencing; however, both assays rely on a long electrophoresis step (Ͼ16 h) under highly controlled conditions and require expertise in interpretation. In addition, the interpretation is complicated in the analysis of isolates that include a minor, resistant subpopulation. Although the mismatch assay involves several post-PCR reactions, overall the procedure is not more technically difficult than a standard PCR assay. The results are straightforward to interpret and are available 4 h after the PCR step. Thus, the mismatch assay for macrolide resistance in MAC is within the capabilities of any laboratory staff with PCR experience, can be readily implemented with a 24-h turnaround time, and is quite cost effective (Ͻ$50 per assay if five or more strains are tested simultaneously).
